$57.92
arrow_drop_up0.60%Key Stats | |
---|---|
Open | $58.49 |
Prev. Close | $57.57 |
EPS | -2.70 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 57.35 | 59.75 |
52 Week Range | 37.55 | 91.10 |
Ratios | |
---|---|
EPS | -2.70 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
What's in Store for ADMA Biologics (ADMA) in Q2 Earnings? - Zacks Investment Research
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals? - The Motley Fool
Vertex (VRTX) Rises 16.5% YTD: Time to Bet On the Stock?
Is CRISPR Therapeutics Stock a Buy? One Analyst Thinks the Biotech Is "Very Undervalued."
CRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing
Is Most-Watched Stock CRISPR Therapeutics AG (CRSP) Worth Betting on Now?
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.